Menu Back toSession-16-Aggregate-Reporting-for-Marketed-Products

Drug Safety and Pharmacovigilance Across the Product Lifecycle

Build a solid foundation in the key concepts of drug safety and pharmacovigilance throughout the medical product development lifecycle. Learn how to comply with regulatory requirements.


Session 16: Aggregate Reporting for Marketed Products

Session Chair(s)

Jill W. Buckley, PharmD

Jill W. Buckley, PharmD

  • Adjunct Assistant Professor
  • Rutgers, the State University of New Jersey, United States
This session will address post-marketing periodic reports, including the US Periodic Adverse Drug Experience Report (PADER) and the EU Periodic Safety Update Report (PSUR in ICH Periodic Benefit-Risk Evaluation Report format).

Contact us

Registration Questions?

Send Email
1.888.257.6457
+1.215.442.6100


Agenda and Event Logistics

Send Email
+1.215.442.6108